On Jul. 21, 2004, Project BioShield Act of 2004 was signed by President George W. Bush. The Act…
On Jun. 26, 2004, the 8th and final report of the Immunization Safety Review Committee was issued by…
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated nearly 20 acres of land at the South Willamette…
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
On May 17, 2004, the United Nations Food and Agriculture Organization endorsed biotech crops, stating biotechnology is a…
On May 11, 2004, the University of Alabama Medical Center’s opened a new $13.5 million 77,000 square foot…
On May 10, 2004, an international call-to-action has been issued by more than one hundred lupus organizations based…
On May 4, 2004, the National Institute of Allergy and Infectious Diseases (NIAID), awarded a new license agreement…
On April 25 known as DNA Day, is a day that commemorates the successful completion of the Human…
On Apr. 24, 2004, the Virginia Bioinformatics Institute, opened its new 59,000-square-foot Bioinformatics Facility I The mission of…
On Apr. 19, 2004, Eli Lilly and Company launched Symbyax in the U.S., the first and only Food…
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
On Mar. 24, 2004, the U.S. Food and Drug Administration (FDA) licensed tetanus and diphtheria toxoids adsorbed for…
On Mar. 16, 2004, the Food and Drug Administration (FDA) released a report addressing the recent slowdown in…
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
On Mar. 19, 2004, University of California, San Diego (UCSD) was awarded $7.5 million to establish The Kavli…
On Mar. 10, 2004, The Kavli Foundation announced a $7.5 million award to establish a Kavli Institute for…
On Mar. 1, 2004, the National incident Management System (NIMS), developed by the Department of Homeland Security (DHS),…
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
On Jan. 28, 2004, the International Tomato Genome Sequencing Project was begun by an international consortium including participants…
On Jan. 9, 2004, the Food and Drug Administration (FDA) announced the approval of Sanofi’s Eloxatin (oxaliplatin) injection…
On Jun. 21, 2004, the Huntsman Cancer Center Hospital was dedicated featuring a full-field digital mammography unit, a…
In 2004, the FDA published “Innovation or Stagnation? — Challenge and Opportunity on the Critical Path to New…
In 2004, William Hagopian, M.D., Ph.D., launched The Environmental Determinants of Diabetes in the Young (TEDDY) study at…
In 2004, the Emergency Use Authorization (EUA) program was established in 2004, when the Project BioShield Act, among…
In 2004, Wisconsin Governor Jim Doyle proposed the Wisconsin Institutes for Discovery (WID), a UW-Madison research enterprise, to…
In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…